Report #2828188

Overview

Sex

Male

Age

Age unknown

State

TX

Recovered

Recovered

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

whole body itching/Systemic and general itching reaction; This non-serious case was reported by a consumer via call center representative and described the occurrence of generalized pruritus in a 59-year-old male patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis. On an unknown date, the patient received Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patient experienced generalized pruritus (Verbatim: whole body itching/Systemic and general itching reaction). The patient was treated with diphenhydramine hydrochloride (Benadryl) and valaciclovir. The outcome of the generalized pruritus was resolved (duration 1 week). It was unknown if the reporter considered the generalized pruritus to be related to Boostrix and Boostrix Pre-Filled Syringe Device. It was unknown if the company considered the generalized pruritus to be related to Boostrix and Boostrix Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 14-FEB-2025 The patient wife reported that a patient had a whole body itching systemic and general itching reaction for one week. The patient had been taking Benadryl and Valaciclovir. The wife wants to know which ingredient had to do with this adverse event. No specific vaccination date given but wife said it was about two weeks ago in Jan 2025, no vaccine detail were obtained in this call. Patient demographics were obtained in this call. No further information was obtained in this call.